The latest ovarian cancer news and blogs from Target Ovarian Cancer, including fundraising, campaigns, research and support news, and blogs from people affected by ovarian cancer. Scroll down for our events listings, including support and fundraising events.

Information is correct at the time of publication, please note information in historical news stories around drug availability or statistics may not still be relevant.

News
Two women reading a guide
Friday 9 November 2018
Today, the National Institute for Health and Care Excellence (NICE) has published some draft guidance about ovarian cancer drug olaparib (Lynparza®). Their current recommendation is that olaparib should not be funded by the NHS, and this is now up for consultation. The National Institute for Health...
News
Mother and daughter go through genetic testing
Monday 22 October 2018
In the news today: the makers of ovarian cancer drug olaparib (Lynparza®) have announced results of a clinical trial showing that the drug is effective in a new group of people - women with ovarian cancer who have a BRCA1 or BRCA2 mutation, who have just completed first-line chemotherapy. Olaparib...
News
Supporters at Pathfinder Northern Ireland
Friday 14 September 2018
Today the Department of Health in Northern Ireland announced a major shake-up that will see much better access to ovarian cancer drugs across the country, designed to make sure people in Northern Ireland have the same access to cancer drugs as the rest of the UK. Among other measures, the...
News
Niraparib approved for women in Scotland
Monday 13 August 2018
After becoming available in England and Wales in June, gamechanging new ovarian cancer drug niraparib (Zejula®) was today approved by the Scottish Medicines Consortium (SMC). Niraparib works by stopping cancer cells from repairing themselves, effectively crippling them. New targeted treatments,...

Pages